AU2001253119A1 - A gene differentially expressed in breast and bladder cancer and encoded polypeptides - Google Patents
A gene differentially expressed in breast and bladder cancer and encoded polypeptidesInfo
- Publication number
- AU2001253119A1 AU2001253119A1 AU2001253119A AU2001253119A AU2001253119A1 AU 2001253119 A1 AU2001253119 A1 AU 2001253119A1 AU 2001253119 A AU2001253119 A AU 2001253119A AU 2001253119 A AU2001253119 A AU 2001253119A AU 2001253119 A1 AU2001253119 A1 AU 2001253119A1
- Authority
- AU
- Australia
- Prior art keywords
- breast
- bladder cancer
- differentially expressed
- encoded polypeptides
- gene differentially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010005003 Bladder cancer Diseases 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 201000005112 urinary bladder cancer Diseases 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006202984A AU2006202984B2 (en) | 2000-04-04 | 2006-07-12 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19446300P | 2000-04-04 | 2000-04-04 | |
US60/194,463 | 2000-04-04 | ||
PCT/US2001/010855 WO2001074859A2 (en) | 2000-04-04 | 2001-04-04 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006202984A Division AU2006202984B2 (en) | 2000-04-04 | 2006-07-12 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2001253119A1 true AU2001253119A1 (en) | 2002-01-03 |
AU2001253119A2 AU2001253119A2 (en) | 2003-03-27 |
AU2001253119B2 AU2001253119B2 (en) | 2006-04-13 |
Family
ID=22717696
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5311901A Pending AU5311901A (en) | 2000-04-04 | 2001-04-04 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
AU2001253119A Ceased AU2001253119B2 (en) | 2000-04-04 | 2001-04-04 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5311901A Pending AU5311901A (en) | 2000-04-04 | 2001-04-04 | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
Country Status (10)
Country | Link |
---|---|
US (3) | US7268207B2 (en) |
EP (1) | EP1272636B8 (en) |
JP (1) | JP2004502408A (en) |
CN (2) | CN1610743A (en) |
AT (1) | ATE404669T1 (en) |
AU (2) | AU5311901A (en) |
CA (1) | CA2413211A1 (en) |
DE (1) | DE60135315D1 (en) |
NZ (1) | NZ522282A (en) |
WO (1) | WO2001074859A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2413211A1 (en) | 2000-04-04 | 2001-10-11 | University Of Rochester | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
US7135278B1 (en) | 2000-09-29 | 2006-11-14 | University Of Rochester | Method of screening for therapeutics for infectious diseases |
US20020164346A1 (en) * | 2001-02-14 | 2002-11-07 | Nicolette Charles A. | Altered peptide ligands |
WO2003004989A2 (en) * | 2001-06-21 | 2003-01-16 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
US7563882B2 (en) * | 2002-06-10 | 2009-07-21 | University Of Rochester | Polynucleotides encoding antibodies that bind to the C35 polypeptide |
US9809654B2 (en) | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
WO2004087058A2 (en) * | 2003-03-28 | 2004-10-14 | Vaccinex, Inc. | Targeted mhc class i alpha3 vaccine delivery systems |
WO2005099361A2 (en) * | 2003-07-10 | 2005-10-27 | Vaccinex, Inc. | MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN |
EP1708751B1 (en) * | 2003-12-04 | 2011-09-28 | Vaccinex, Inc. | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
US20050266425A1 (en) * | 2003-12-31 | 2005-12-01 | Vaccinex, Inc. | Methods for producing and identifying multispecific antibodies |
US20050260659A1 (en) * | 2004-04-23 | 2005-11-24 | Exagen Diagnostics, Inc. | Compositions and methods for breast cancer prognosis |
AU2007261247A1 (en) * | 2006-06-22 | 2007-12-27 | Vaccinex, Inc. | Anti-C35 antibodies for treating cancer |
US9603922B2 (en) * | 2007-02-21 | 2017-03-28 | Vaccinex, Inc. | Modulation of NKT cell activity with antigen-loaded CD1d molecules |
JP2010540534A (en) | 2007-09-28 | 2010-12-24 | イントレキソン コーポレーション | Therapeutic gene switch constructs and bioreactors for the expression of biotherapeutic molecules and uses thereof |
NZ586544A (en) | 2007-12-26 | 2012-07-27 | Vaccinex Inc | Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods |
PT2385980T (en) | 2009-01-08 | 2018-06-26 | Albert Einstein College Medicine Inc | Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof |
JP5784583B2 (en) * | 2009-04-01 | 2015-09-24 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | Semaphorin 3C (SEMA3C) inhibitory therapeutic agent, method and use |
CN102639555B (en) * | 2009-09-24 | 2015-11-25 | 加利福尼亚大学董事会 | Bladder cancer specific ligand peptide |
US9371352B2 (en) | 2013-02-08 | 2016-06-21 | Vaccinex, Inc. | Modified glycolipids and methods of making and using the same |
RU2729116C2 (en) * | 2015-12-16 | 2020-08-04 | Гритстоун Онколоджи, Инк. | Identification, production and use of neoantigens |
IL273030B2 (en) * | 2017-09-05 | 2024-03-01 | Gritstone Bio Inc | Neoantigen identification for t-cell therapy |
KR20200087143A (en) | 2017-10-10 | 2020-07-20 | 그릿스톤 온콜로지, 인코포레이티드 | Identification of new antigens using hot spots |
JP2021503897A (en) | 2017-11-22 | 2021-02-15 | グリットストーン オンコロジー インコーポレイテッド | Reduced junction epitope presentation for nascent antigens |
KR102318018B1 (en) | 2019-07-05 | 2021-10-28 | 한국생산기술연구원 | Manufacturing mehtod of mandrel for manufacturing micro product, manufacturing method of mold for manufacturing micro product and mold for manufacturing micro product |
US20230109070A1 (en) * | 2019-10-18 | 2023-04-06 | The Board of Trustees og the Leland Standford Junior University | Clinical- and industrial-scale intact-tissue sequencing |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0581600A (en) * | 1991-04-18 | 1993-04-02 | Fujitsu Ltd | System monitoring processing system in hyperbolic navigation system |
IL106610A0 (en) | 1992-08-07 | 1993-12-08 | Cytel Corp | Hla binding peptides and their uses |
ATE466869T1 (en) | 1993-03-05 | 2010-05-15 | Epimmune Inc | METHOD FOR PRODUCING IMMUNOGENIC HLA-A2.1-BINDING PEPTIDES |
US5856131A (en) * | 1997-02-24 | 1999-01-05 | Incyte Pharmaceuticals, Inc. | Human selenoprotein |
US7026447B2 (en) * | 1997-10-09 | 2006-04-11 | Human Genome Sciences, Inc. | 53 human secreted proteins |
JP2002507387A (en) | 1997-12-24 | 2002-03-12 | コリクサ コーポレイション | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
WO1999037775A2 (en) * | 1998-01-26 | 1999-07-29 | Genquest, Inc. | Compositions and methods for detecting and treating breast cancer |
US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
US20020052308A1 (en) * | 1999-03-12 | 2002-05-02 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
EP1248800A2 (en) | 1999-11-30 | 2002-10-16 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
CA2413211A1 (en) * | 2000-04-04 | 2001-10-11 | University Of Rochester | A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
AU2001255326B2 (en) * | 2000-04-12 | 2005-12-15 | University Of Rochester | Targeted vaccine delivery systems |
US20050196755A1 (en) | 2000-11-17 | 2005-09-08 | Maurice Zauderer | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
JP4368196B2 (en) | 2000-11-17 | 2009-11-18 | ユニバーシティー オブ ロチェスター | In vitro methods for producing and identifying immunoglobulin molecules in eukaryotic cells |
US7563882B2 (en) | 2002-06-10 | 2009-07-21 | University Of Rochester | Polynucleotides encoding antibodies that bind to the C35 polypeptide |
WO2005099361A2 (en) * | 2003-07-10 | 2005-10-27 | Vaccinex, Inc. | MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN |
EP1708751B1 (en) | 2003-12-04 | 2011-09-28 | Vaccinex, Inc. | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
-
2001
- 2001-04-04 CA CA002413211A patent/CA2413211A1/en not_active Abandoned
- 2001-04-04 CN CNA018178049A patent/CN1610743A/en active Pending
- 2001-04-04 AU AU5311901A patent/AU5311901A/en active Pending
- 2001-04-04 DE DE60135315T patent/DE60135315D1/en not_active Expired - Lifetime
- 2001-04-04 US US09/824,787 patent/US7268207B2/en not_active Expired - Fee Related
- 2001-04-04 CN CN200910007590A patent/CN101643732A/en active Pending
- 2001-04-04 NZ NZ522282A patent/NZ522282A/en unknown
- 2001-04-04 AT AT01926595T patent/ATE404669T1/en not_active IP Right Cessation
- 2001-04-04 AU AU2001253119A patent/AU2001253119B2/en not_active Ceased
- 2001-04-04 WO PCT/US2001/010855 patent/WO2001074859A2/en active IP Right Grant
- 2001-04-04 EP EP01926595A patent/EP1272636B8/en not_active Expired - Lifetime
- 2001-04-04 JP JP2001572548A patent/JP2004502408A/en active Pending
-
2006
- 2006-11-20 US US11/601,669 patent/US20070081942A1/en not_active Abandoned
-
2009
- 2009-02-26 US US12/393,860 patent/US7910551B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001253119A1 (en) | A gene differentially expressed in breast and bladder cancer and encoded polypeptides | |
EP1531848A4 (en) | Gene differentially expressed in breast and bladder cancer and encoded polypeptides | |
AU2003304203A1 (en) | Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same | |
AU2001253140A1 (en) | Tumor markers in ovarian cancer | |
AU7721500A (en) | Colon and colon cancer associated polynucleotides and polypeptides | |
AU2001278070A1 (en) | Basal cell markers in breast cancer and uses thereof | |
EP1568773A2 (en) | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | |
AU2225000A (en) | Sequence-determined dna fragments and corresponding polypeptides encoded thereby | |
GB0002835D0 (en) | Drug resistance in cancer | |
AU2001280608A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
AU2002362613A1 (en) | Galectins-1-and-4 in tumor development | |
AU2002243314A1 (en) | Immunogenic cancer peptides and uses thereof | |
AU4171001A (en) | Membrane estrogen receptor-directed therapy in breast cancer | |
AU8026300A (en) | Sodd gene expression in cancer | |
IL145775A0 (en) | 13 transmembrane protein expressed in prostate cancer | |
IL145719A0 (en) | Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof | |
AU2002215111A1 (en) | Ruthenium-aryl-compounds in cancer therapy | |
AU5416700A (en) | Differentially expressed genes in prostate cancer | |
AU2001236782A1 (en) | 34p3d7: a tissue specific protein highly expressed in prostate cancer | |
AU2001287004A1 (en) | Xage-1, a gene expressed in multiple cancers, and uses thereof | |
AU2001238144A1 (en) | 83p5g4: a tissue specific protein highly expressed in prostate cancer | |
AU2001268466A1 (en) | 55p4h4: gene expressed in various cancers | |
GB2356437B (en) | Improvements in swashplate design | |
AU2002364077A8 (en) | Gene expression profiles in stomach cancer | |
AU1926699A (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis |